Kailera Therapeutics (KLRA) vs Korsana Biosciences (KRSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Korsana Biosciences is the larger company by market cap ($1.53 billion vs $1.30 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KLRA | KRSA |
|---|---|---|
| Share price | $10.00 | $33.51 |
| Market cap | $1.30B | $1.53B |
| 1-day change | -5.03% | +6.37% |
| YTD return | — | +276.94% |
| 1-year return | — | +89.97% |
| 5-year return | — | -91.10% |
| EPS (TTM) | $-4.51 | $-7.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $2.07M |
| Revenue growth (YoY) | — | +3.70% |
| Net income (latest FY) | — | $-3.53M |
| Operating margin | — | -239.78% |
| Net margin | — | -170.11% |
| 52-week high | $28.23 | $59.36 |
| 52-week low | $9.76 | $7.19 |
| Distance from 52-week high | -64.58% | -43.55% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +324.00% | +31.30% |
| Average volume | 861.01K | 32.06K |
| Shares outstanding | 129.64M | 45.54M |
| Employees | 145 | 19 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
About Korsana Biosciences
KRSA stock →Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
KLRA vs KRSA FAQ
Which is bigger, Kailera Therapeutics or Korsana Biosciences?
Korsana Biosciences (KRSA) is larger, with a market capitalization of $1.53B compared with $1.30B for Kailera Therapeutics (KLRA).
Are Kailera Therapeutics and Korsana Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.